In our cohort, the expression of key downstream RELA targets, including BCL2A1, CCL22, CCL4, CSF1, HMOX1, and MMP9, was elevated in TFE3‐RCC tissues (Figure 7D,E). The gene discussed is CCL22; the disease is renal cell carcinoma.